Vanadocene-functionalized mesoporous silica nanoparticles: platforms for the development of theranostic materials against breast cancer

Biomed Mater. 2024 Mar 6;19(3). doi: 10.1088/1748-605X/ad2c1c.

Abstract

Nanoscale materials have demonstrated a very high potential in anticancer therapy by properly adjusting their functionalization and physicochemical properties. Herein, we report the synthesis of some novel vanadocene-loaded silica-based nanomaterials incorporating four different S-containing amino acids (penicillamine, methionine, captopril, and cysteine) and different fluorophores (rhodamine B, coumarin 343 or Alexa Fluor™ 647), which have been characterized by diverse solid-state spectroscopic techniques viz; FTIR, diffuse reflectance spectroscopies,13C and51V solid-state NMR spectroscopy, thermogravimetry and TEM. The analysis of the biological activity of the novel vanadocene-based nanostructured silicas showed that the materials containing cysteine and captopril aminoacids demonstrated high cytotoxicity and selectivity against triple negative breast cancer cells, making them very promising antineoplastic drug candidates. According to the biological results it seems that vanadium activity is connected to its incorporation through the amino acid, resulting in synergy that increases the cytotoxic activity against cancer cells of the studied materials presumably by increasing cell internalization. The results presented herein hold significant potential for future developments in mesoporous silica-supported metallodrugs, which exhibit strong cytotoxicity while maintaining low metal loading. They also show potential for theranostic applications highlighted by the analysis of the optical properties of the studied systems after incorporating rhodamine B, coumarin 343 (possible)in vitroanticancer analysis, or Alexa Fluor™ 647 (in vivostudies of cancer models).

Keywords: amino acid; cytotoxicity; mesoporous silica nanoparticles; metallodrug; theranosis; vanadocene.

MeSH terms

  • Antineoplastic Agents* / chemistry
  • Breast Neoplasms* / drug therapy
  • Captopril / therapeutic use
  • Cysteine / therapeutic use
  • Female
  • Humans
  • Nanoparticles* / chemistry
  • Porosity
  • Precision Medicine
  • Silicon Dioxide / chemistry

Substances

  • Silicon Dioxide
  • Cysteine
  • Captopril
  • Antineoplastic Agents